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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AS  Automated Screening 
BT  Bagolini Test 
CT  Cover Test 
CV  Colour Vision 
EI  Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test  
NICU  Neonatal-intensive care unit 
PCT  Prism Cover Test 
PM  Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
Ret  Retinoscopy 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
USAID United States Agency for International Development 
VA  Visual Acuity  
WHO  World Health Organisation  
WT  Worth Test 
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3 Population and Healthcare Overview 
The population of Macedonia is 2,083,160 (World Bank, 2018a) and birth rate is estimated 
at 11.28 births/1,000 population in 2016 (World Bank, 2018b). The change in population and 
birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively. 
Macedonia has a reported population density of 83 people per square kilometre in 2017 and 
this has risen from 59 people per square kilometre in 1961 (World Bank, 2018c). In terms of 
healthcare facilities, the total density of hospitals in 2013 was 4.08 per 100,000 population 
(WHO, 2016a). Infant mortality in 2017 is estimated at 12 deaths/1,000 live births in total 
(World Bank, 2018d). 
The average life expectancy in Macedonia is estimated at 75.6 years (World Bank, 2018e), 
with a death rate of 9.8 deaths/1,000 population in 2016 (World Bank, 2018f). Macedonia 
has a gross national income per capita (PPP int. $, 2013) of $11,000 (WHO, 2016b). The 
estimated total expenditure on health per capita in 2014) was $851 (Intl $) and the total 
expenditure on health in 2014 as percentage of GDP was 6.5% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in Macedonia between 1960 and 2017 
 
Source: Information sourced from World Bank (2018)
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4 Vision Screening Commissioning and Guidance 
Vision screening in Macedonia is organised both nationally and regionally, with no variation 
between protocols. Vision screening is funded through a non-public organisation (the country 
representative is not able to reveal the name of this) in collaboration with the Ministry of 
Health and United States Agency for International Development (USAID). Vision problems 
that are detected on vision screening or eye examinations are treated through funding from 
public health insurance, however, after 1 year of age, the patient pays 10% of the total cost.  
Vision screening is embedded into a general preventative child healthcare screening system. 
The American Guidelines for Retinopathy of Prematurity (ROP) are used to determine some 
of the content and guidelines for vision screening. The vision screening programme was 
started in 2008. There has been no change to the programme since its implementation, 
however it is reviewed every two years, with paediatric ophthalmologists deciding upon any 
revisions needed. There is no specific funding for these reviews, it is carried out within the 
ĚŽĐƚŽƌ ?ƐƌŽůĞ ?
Vision screening takes place in hospitals, kindergartens and schools and is conducted by 
ophthalmologists. There are two ophthalmologists that are trained to examine for ROP and a 
further 6-8 paediatric ophthalmologists that can conduct vision screening. There are general 
professionals who do not screen, but could do so with additional training, this includes nurses 
working in eye departments and special needs assistants that work in schools for children 
with visual impairment. There is specific training provided for vision screening which takes 
four years to complete. The content of the training is regularly updated, monitored or 
revalidated and is accredited.  
There are no methods of quality monitoring for vision screening imposed by the government 
and no information is collected. Research has not been conducted concerning the vision 
screening programme in Macedonia, and there has been no cost-effectiveness analysis.  
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5 Screening programme  
In Macedonia, ROP, congenital eye defects and reduced visual acuity are the vision screening 
target condition. The health care professionals delivering vision screening, venue for 
screening and tests used vary depending on the age of the child as shown in Tables 1, 2 and 
3 respectively. Specific details of the screening offered within each age group are described 
more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened by an ophthalmologist in a 
neonatology unit of a hospital. The tests used include eye inspection, red reflex testing, eye 
motility, retinal examination and pupillary reflexes. Every baby of less than 36 to 37 
gestational weeks, regardless of birth weight, are screened, as well as any baby with a birth 
ǁĞŝŐŚƚA? ? ? ? ?ŐƌĂŵƐ ? 
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened by an ophthalmologist in a 
hospital. The tests used include eye inspection, fixation, red reflex testing, eye motility, retinal 
examination and pupillary reflexes. Babies are referred for further diagnostic examination 
after two abnormal or inconclusive test results.  
5.3 Vision screening - 3 months to 36 months 
Children aged 3 to 36 months are screened by an ophthalmologist at a University Clinic for 
eye diseases; there are three university eye clinics in Macedonia. The tests that are conducted 
include eye inspection, fixation, red reflex testing, eye motility, retinal examination, pupillary 
reflexes and cover test. Children are referred for further diagnostic examination after two 
abnormal or two inconclusive test results. 
5.4 Vision screening - 36 months to 7 years 
Children aged from 36 months to 7 years are screened by an ophthalmologist at a University 
Clinic. The tests that are conducted include eye inspection, fixation, red reflex testing, eye 
motility, retinal examination, pupillary reflexes, cover test, visual acuity measurement, colour 
vision and autorefraction (Topcon RM 8900). The visual acuity measurement is conducted for 
the first time at 3 years of age using Snellen optotype charts, Tumbling E visual acuity charts 
and special charts with pictures and symbols, all of which are linear crowded charts. Visual 
acuity is measured again at 3.5, 4, 5 and 6 years of age; all of which are conducted by an 
ophthalmologist. All children are offered this screening at each of the ages stated. Children 
are referred for further diagnostic examination after two abnormal or two inconclusive test 
results. 
Summary Vision Screening Data: Macedonia                                                                                            
 
5 
 
Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 
Ophthalmologist 
Preterm babies  9 
0 to 3 months  9 
3 to 36 months  9 
3 to 7 years  9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 EI Fix RR EM RE PR CT VA CV AR 
Preterm babies  9 × 9 9 9 9 × × × × 
0 to 3 months  9 9 9 9 9 9 × × × × 
3 to 36 months  9 9 9 9 9 9 9 × × × 
3 to 7 years  9 9 9 9 9 9 9 9 9 9 
Key: 
EI: Eye Inspection; Fix: Fixation; RR: Red Reflex Testing; EM: Eye Motility; RE: Retinal Examination; PR: Pupillary Reflexes; CT: Cover Test; VA: 
Visual Acuity Measurement; CV: Colour Vision; AR: Autorefraction 
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Table 3: Location of vision screening for each age group  
Table 3 
Hospital University Eye Disease Clinic 
Preterm babies  9 × 
0 to 3 months  9 × 
3 to 36 months  × 9 
3 to 7 years  × 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error in infants from 6 months of age. It provides objective results and 
is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss.  
In Macedonia, automated screening is conducted in some areas using the Topcon RM 8900. 
The cost of this device is 5,000 Euros. The maintenance costs and years before a replacement 
is needed are not known.  
This test is conducted at age 3 years, with referral for amblyogenic risk factors, including 
refractive errors, anisometropia, strabismus, media opacity, or reduced stereovision. If a child 
passes the visual acuity test, but fails the autorefraction, that child will be referred and treated 
if needed. Testing is conducted on all children, as opposed to a select group who are 
borderline/fails on visual acuity testing. There is no comparative data between areas that do 
use this and do not use this device. 
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7 Provision for Visually Impaired  
In Macedonia, there is one school for blind or severely visually impaired children; this is 
located in Skopje, which has specialised school programmes.  There are 50 children, from the 
age of 7 to 18 years that attend this school. There are also two day centres for children with 
visual impairment, one in Skopje and one located in Veles (another city in Macedonia).  The 
centre in Skopje caters for children up to 6 years of age and has a capacity up to 15 children. 
The centre in Veles caters for children up to 18 years of age. However, at the moment there 
are 6 children from the age of 5-6 years. These children have financial support from the 
Macedonian Government. 
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
There is no data available concerning the prevalence of treated or untreated amblyopia, 
persistent amblyopia, or strabismus.  
8.2 Coverage 
It is not known how many children are invited for vision screening; however, every premature 
baby is invited with a letter by a neonatologist. The coverage and attendance of all vision 
screening programmes, before the age of 7 years, is not known. 
8.3 Screening evaluation 
The percentage of false negative results of vision screening is estimated at 2% and the 
percentage of false positive referrals is estimated at 3%. There is no data pertaining to the 
positive predictive value of a refer result after vision screening, the sensitivity of vision 
screening, or the specificity of vision screening.  
8.4 Treatment success 
The percentage of children attending their referral appointment is not known as there is no 
registration documentation of noncompliance with referral after an abnormal screening test 
result. It is estimated that all children who are identified as having strabismus, before the age 
of 7 to 8 years, are treated. The same is true for children with amblyopia. It is estimated that 
7 patients per year are treated for congenital cataract and amblyopia with strabismus per 
year, by an ophthalmologist. However, there is no data available concerning the success of 
treatment or the number of children who go untreated, per year. 
Children who fail testing are referred to an ophthalmologist who is the only professional who 
prescribes glasses for children under 7 years of age. Other treatment options include 
patching, penalisation with glasses, atropine and cataract surgery where indicated. Not all 
children are treated due to capacity problems and also payment problems. 
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The monthly salary costs) for vision screening professionals is estimated at 550 Euros. 
Ophthalmologists get paid 5 to 8 Euros per hour in Macedonia. Training of general 
preventative child healthcare professionals is not known, there is no access to this data. 
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients with refractive amblyopia and strabismic 
amblyopia, including follow-up is not known. In Macedonia, for a child under the age of 1 
year, there is no payment needed for treatment, follow-up or for surgery as this is covered by 
public state health insurance. After the age of 1 year, for medical examinations, the patient 
pays 10% of the total cost and 90% is covered by public state health insurance. The total cost 
is dependent on the number of visits to the ophthalmologist, this data is not available.  
9.3 Cost of Treatment for strabismus  
 The estimated costs for strabismus surgery, including follow-up is 300 Euros. Patients under 
public health insurance pay 30 Euros and the remaining 270 Euros is covered by the insurance. 
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery. Including follow-up of deprivation 
amblyopia is 450 Euros in public hospitals; the patient pays 45 Euros and the rest is covered 
by public health insurance. The cost in a private hospital rises to 1,000 Euros. 
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